Quantcast

Latest Oligonucleotide Stories

2009-10-22 08:41:00

BASKING RIDGE, N.J., Oct. 22 /PRNewswire/ -- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced today Ellen McDonald, MBA, Senior Vice President and Chief Business Officer, will be presenting at the BIO Investor Forum at the Palace Hotel in San Francisco, California at 2:00 PM (PDT) on Thursday, October 29, 2009. Ms. McDonald's presentation will include an overview of the Company's pipeline with emphasis on...

2009-10-05 07:30:00

BASKING RIDGE, N.J., Oct. 5 /PRNewswire/ -- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced today that David J. Mazzo, Ph.D., President and Chief Executive Officer, will be presenting at the Japan Biopharma Conference 2009 at the Conrad Hotel in Tokyo, Japan. Dr. Mazzo's presentation is scheduled for 2:40pm (GMT +9:00) on October 6, 2009. The Conference brings together premier biotechnology companies...

2009-10-04 15:00:11

Imagine a surgical patient on a blood-thinning drug who starts bleeding more than expected, and an antidote that works immediately "“ because the blood thinner and antidote were designed to work together. Researchers at Duke University Medical Center have engineered a way to do this for an entire, versatile class of drugs called aptamers and published their findings in Nature Medicine. "With any anticoagulant, you are trying to reduce your chances of having clotting because it can lead...

2009-09-17 19:54:00

BASKING RIDGE, N.J., Sept. 17 /PRNewswire/ -- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced today that the European Patent Office (EPO) has notified the Company of its intent to grant a patent with claims directed to oligonucleotide modulators of blood coagulation factor aptamers in EP 1401853. This new patent grant in the Company's portfolio extends the scope and breadth of Regado's intellectual...

2009-09-16 07:00:00

SAN DIEGO, Sept. 16 /PRNewswire/ -- TriLink BioTechnologies, Inc. (TriLink), announced that it is relaunching its oligonucleotide radiolabeling services. TriLink discontinued the service in May 2009 after ordering trends in 2008 suggested that the market may no longer require it. However, strong customer feedback led TriLink to bring back its radiolabeling services in September 2009. "We've learned that no other suppliers have exactly our expertise in this area. We felt discontinuing this...

2009-09-04 07:30:00

BASKING RIDGE, N.J., Sept. 4 /PRNewswire/ -- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced today that Ellen McDonald, MBA, Senior Vice President and Chief Business Officer, will be presenting at the Thomas Weisel Partners Healthcare Conference 2009 in Boston, MA at 9:45 AM on Friday, September 11, 2009 (EDT). Ms. McDonald's presentation will include an overview of the Company's pipeline with emphasis...

2009-09-03 07:30:00

BASKING RIDGE, N.J., Sept. 3 /PRNewswire/ -- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced today that David J. Mazzo, Ph.D., President and Chief Executive Officer, will be presenting at the 11th Annual Healthcare Conference of the Rodman & Renshaw Global Investment Conference in New York, NY at 4:30 PM on Thursday, September 10, 2009 (EDT). Dr. Mazzo's presentation will include an overview of the...

5258660def903a7f555ee9e20aa9349b1
2009-07-28 09:40:00

Spinal Muscular Atrophy is the second-leading cause of infant mortality in the world.Ravindra Singh, associate professor in biomedical sciences at Iowa State University's College of Veterinary Medicine, would like to see Spinal Muscular Atrophy lose its high ranking and even slide off the list altogether.Most Spinal Muscular Atrophy sufferers -- more than 95 percent -- have a mutated or deleted gene called Survival Motor Neuron 1 (SMN1) that doesn't correctly do its job of creating functional...

2009-06-25 07:00:00

LOMBARD, Ill., June 25 /PRNewswire/ -- Orochem Technologies Inc., a leading provider of reagents and devices that serves the bioanalysis, drug discovery, genomics and proteomics markets today announced the acquisition of Oligonet, Inc. a Custom Oligonucleotide Synthesis Business located in Gaithersburg, MD. With this acquisition, Orochem will become a significant player in the custom oligo synthesis market having already been supporting oligonucleotide synthesis establishment with several...

2009-06-24 07:00:00

SAN DIEGO, June 24 /PRNewswire/ -- TriLink BioTechnologies (TriLink), announced that it has signed a sales and license agreement with Glen Research Corporation to sell TriLink's CleanAmp(TM) Amidites. Glen Research can now sell the patented CleanAmp(TM) Amidites produced by TriLink to third parties for use in the production of CleanAmp(TM) Primers. TriLink's CleanAmp(TM) technology offers a less expensive approach to high stringency PCR. CleanAmp(TM) is a unique solution, where the primer or...


Word of the Day
caparison
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.
Related